Company news
Immuron Limited news in 2020
Immuron Limited's news releases, calls and decks from 2020, newest first.
Immuron SARS-CoV-2 Research Agreement with Monash University
December 14, 2020
Immuron Receives AUD $358,280 R&D Tax Concession Refund
November 23, 2020
US DoD NMRC Reports Positive Response to Vaccine
November 8, 2020
Immuron Travelers Diarrhea Market Update
October 12, 2020
Appendix 4E and 2020 Financial Report
August 31, 2020
Immuron Announces US$20.0 Million Registered Direct Offering
July 21, 2020
Immuron Reports Neutralizing activity Against SARS-CoV-2
July 21, 2020
US DoD Receives FDA Guidance on clinical development plans
July 20, 2020
IMC & CSIRO to produce oral therapeutic for DoD evaluation
June 19, 2020
Response to ASX Price Query
June 10, 2020
Immuron Global Sales Up 60%
April 20, 2020
Resignation of Managing Director and cuts amid Covid19
March 24, 2020
North American Travelan sales up 98% to Dec 2019
January 27, 2020
Decks in 2020
- Shareholder Meeting (October 2020)
Shareholder meeting · 11 slides · Oct 29, 2020